data_2kt2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kt2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.69 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.696 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.552 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.573 ' HB1' HG12 ' A' ' 33' ' ' VAL . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 23' ' ' GLU . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.87 ' HA ' HG12 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.573 HG12 ' HB1' ' A' ' 15' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.822 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.822 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.478 ' HB ' ' HG1' ' A' ' 48' ' ' THR . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' HG21 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.478 ' HG1' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.481 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HA ' HD11 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 42' ' ' LEU . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 64' ' ' ALA . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.66 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.42 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 9' ' ' MET . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.477 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.961 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.693 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HA ' HD11 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 64' ' ' ALA . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 62' ' ' TYR . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.961 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 40' ' ' ALA . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.744 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.693 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.744 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.866 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.693 HD12 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.818 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.522 HG11 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA3' HG22 ' A' ' 48' ' ' THR . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.818 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mm-40 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 15' ' ' ALA . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB3' HD13 ' A' ' 6' ' ' ILE . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.866 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.452 ' HB2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.738 ' HE2' ' HB3' ' A' ' 62' ' ' TYR . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.517 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 HG21 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.667 HG23 ' HB1' ' A' ' 15' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.485 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.644 HG21 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HA ' HD13 ' A' ' 53' ' ' LEU . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ALA . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 50' ' ' PRO . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.478 HG22 ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.853 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 57' ' ' VAL . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.738 ' HB3' ' HE2' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 6' ' ' ILE . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.651 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD21 HD22 ' A' ' 53' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.561 ' H ' HG11 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.621 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.621 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 HD11 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 50' ' ' PRO . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.848 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB2' HG13 ' A' ' 57' ' ' VAL . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.53 HD11 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HA ' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.573 HG22 ' HE3' ' A' ' 9' ' ' MET . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.887 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.819 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.414 HG22 ' HE1' ' A' ' 9' ' ' MET . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 42' ' ' LEU . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.689 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 ' HB3' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 49' ' ' SER . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.819 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.887 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.727 HD12 HG12 ' A' ' 18' ' ' VAL . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.452 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.426 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.489 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 6' ' ' ILE . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.596 HG21 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.646 ' HD2' HG13 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.2 m170 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.411 HG12 HD12 ' A' ' 22' ' ' LEU . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HB2' HG21 ' A' ' 33' ' ' VAL . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 28' ' ' VAL . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.45 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 19' ' ' LYS . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.826 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.606 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.683 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.875 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' H ' HG11 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.499 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.411 ' HB3' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HA ' ' HG1' ' A' ' 54' ' ' THR . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 49' ' ' SER . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.441 HD11 HD22 ' A' ' 42' ' ' LEU . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.617 ' HG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.875 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.856 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.61 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.6 HD12 HG12 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 14' ' ' CYS . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.679 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.817 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HB1' ' A' ' 56' ' ' ALA . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.61 HG22 ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.702 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.536 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.762 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.502 ' HE2' ' HB3' ' A' ' 62' ' ' TYR . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.697 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 57' ' ' VAL . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 28' ' ' VAL . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 25' ' ' VAL . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.697 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.667 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.536 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 9.0 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.797 HG21 HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 49' ' ' SER . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' THR . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.828 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.807 HG23 ' HA ' ' A' ' 65' ' ' THR . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.807 ' HA ' HG23 ' A' ' 54' ' ' THR . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 35.6 m170 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.843 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 57' ' ' VAL . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 33' ' ' VAL . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 18' ' ' VAL . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 27' ' ' GLY . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.546 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.893 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG21 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.885 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 49' ' ' SER . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.617 HG21 ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.843 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.741 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.578 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 53' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 15' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.691 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' HD12 ' A' ' 53' ' ' LEU . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 22' ' ' LEU . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 18' ' ' VAL . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.741 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 61.6 m80 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 39' ' ' THR . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.626 ' HE3' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.69 HG13 ' HE2' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.737 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.921 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 57' ' ' VAL . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 HG12 ' A' ' 18' ' ' VAL . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.626 HG21 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 HD23 ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG13 ' HD2' ' A' ' 46' ' ' PRO . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.674 ' HD2' HG13 ' A' ' 45' ' ' VAL . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' VAL . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 53' ' ' LEU . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 66' ' ' LEU . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.62 HG21 HG13 ' A' ' 18' ' ' VAL . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.921 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 54' ' ' THR . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG21 ' HE2' ' A' ' 9' ' ' MET . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.566 ' HE3' HG22 ' A' ' 18' ' ' VAL . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.566 HG22 ' HE3' ' A' ' 9' ' ' MET . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HD11 ' A' ' 53' ' ' LEU . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 50' ' ' PRO . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.875 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.875 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.655 0.264 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.594 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.847 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.556 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG21 HG12 ' A' ' 57' ' ' VAL . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HG3' ' HB1' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 44' ' ' ILE . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB1' ' HG3' ' A' ' 23' ' ' GLU . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.787 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.847 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.418 HD13 ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.555 HG21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HA ' HD12 ' A' ' 53' ' ' LEU . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 50' ' ' PRO . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 64' ' ' ALA . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.869 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m170 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 33' ' ' VAL . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 57' ' ' VAL . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.661 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 6' ' ' ILE . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.661 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.848 HG21 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.744 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.618 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.56 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' A' ' 9' ' ' MET . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 18' ' ' VAL . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.5 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.634 HG22 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.6 HD13 HD23 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HA ' HG13 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.62 ' HA3' HG23 ' A' ' 48' ' ' THR . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB1' ' HG3' ' A' ' 23' ' ' GLU . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.6 HD23 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.62 HG23 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HA ' HD12 ' A' ' 53' ' ' LEU . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 50' ' ' PRO . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.8 m170 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.797 HD23 HD13 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.765 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.882 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.765 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.903 ' HA ' HG12 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.729 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.729 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 19' ' ' LYS . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.882 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.797 HD13 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HA ' HD13 ' A' ' 53' ' ' LEU . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' ALA . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 50' ' ' PRO . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' HB1' ' A' ' 64' ' ' ALA . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 5' ' ' LYS . . . . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 65' ' ' THR . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.663 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.914 HG21 ' HE1' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.914 ' HE1' HG21 ' A' ' 6' ' ' ILE . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.541 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 57' ' ' VAL . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 33' ' ' VAL . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 HD21 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.541 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 HG21 ' HA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 53' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD12 HD11 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 52' ' ' ALA . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.747 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.663 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.93 0.395 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.39 77.96 8.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.843 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.764 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 6.9 m80 -124.96 143.22 51.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.358 172.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.69 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.696 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.552 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' HB1' HG12 ' A' ' 33' ' ' VAL . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 23' ' ' GLU . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.87 ' HA ' HG12 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.573 HG12 ' HB1' ' A' ' 15' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.822 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.822 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.478 ' HB ' ' HG1' ' A' ' 48' ' ' THR . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' HG21 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.478 ' HG1' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.481 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HA ' HD11 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 42' ' ' LEU . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 64' ' ' ALA . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.66 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.2 120.26 2.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.764 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 24.2 t70 -79.2 91.31 4.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.997 0.427 . . . . 0.0 112.001 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.465 173.753 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.06 114.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.266 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.71 118.5 27.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.42 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 9' ' ' MET . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.961 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.693 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HA ' HD11 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 64' ' ' ALA . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 62' ' ' TYR . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.961 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.68 44.84 1.53 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.25 99.91 1.23 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.95 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.867 176.442 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HE2' ' HB3' ' A' ' 41' ' ' GLN . 10.2 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.99 125.83 25.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.022 -174.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -92.26 124.26 36.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 40' ' ' ALA . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.744 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.693 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.744 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.866 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.693 HD12 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.818 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.522 HG11 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA3' HG22 ' A' ' 48' ' ' THR . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.818 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mm-40 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 15' ' ' ALA . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB3' HD13 ' A' ' 6' ' ' ILE . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.866 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.91 85.06 1.41 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.69 -35.08 79.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.282 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.72 0.295 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.45 149.43 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.452 ' HB2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -113.17 114.49 26.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.738 ' HE2' ' HB3' ' A' ' 62' ' ' TYR . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.517 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 HG21 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.667 HG23 ' HB1' ' A' ' 15' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.591 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.485 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.644 HG21 HG23 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HA ' HD13 ' A' ' 53' ' ' LEU . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ALA . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 50' ' ' PRO . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.478 HG22 ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.853 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 57' ' ' VAL . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.738 ' HB3' ' HE2' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.03 128.51 52.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -107.07 150.01 26.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.01 177.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.89 147.3 53.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.844 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.9 150.95 32.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.903 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 6' ' ' ILE . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.651 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD21 HD22 ' A' ' 53' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.561 ' H ' HG11 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.621 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.621 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 HD11 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 50' ' ' PRO . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.848 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB2' HG13 ' A' ' 57' ' ' VAL . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.88 107.21 9.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -61.66 -27.67 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.447 -178.422 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 2.3 tpt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.65 123.52 28.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.339 0.59 . . . . 0.0 111.074 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -118.13 135.23 54.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.53 HD11 HD23 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HA ' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.573 HG22 ' HE3' ' A' ' 9' ' ' MET . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.887 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.819 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.414 HG22 ' HE1' ' A' ' 9' ' ' MET . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 42' ' ' LEU . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.689 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 ' HB3' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' HG3' ' HE2' ' A' ' 1' ' ' MET . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 49' ' ' SER . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.819 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.887 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.73 97.7 5.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.26 130.33 42.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.237 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 O-C-N 123.713 0.633 . . . . 0.0 110.882 -177.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.166 0.508 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 131.34 47.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.365 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -112.96 122.71 48.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.727 HD12 HG12 ' A' ' 18' ' ' VAL . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.452 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.426 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.489 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 6' ' ' ILE . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.596 HG21 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.646 ' HD2' HG13 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.674 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -154.25 121.78 5.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HA ' ' CD2' ' A' ' 3' ' ' HIS . 23.3 t70 -79.44 -32.1 42.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.571 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.92 -178.25 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 152.33 38.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.976 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.842 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 28.2 m170 -90.4 124.52 35.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG12 HD12 ' A' ' 22' ' ' LEU . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HB2' HG21 ' A' ' 33' ' ' VAL . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 28' ' ' VAL . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.45 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 19' ' ' LYS . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.826 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.606 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.63 105.67 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.842 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -68.16 -53.99 21.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.457 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.683 178.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 m 67.43 81.5 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.243 0.544 . . . . 0.0 110.553 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.529 ' H ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.45 132.57 34.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 -178.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.683 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.875 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' H ' HG11 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.499 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' HB3' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HA ' ' HG1' ' A' ' 54' ' ' THR . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 49' ' ' SER . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.441 HD11 HD22 ' A' ' 42' ' ' LEU . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.617 ' HG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.856 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.875 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.856 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.61 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.24 106.61 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 3' ' ' HIS . 16.4 t70 -160.62 -64.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.407 0.623 . . . . 0.0 110.175 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.553 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HB3' ' H ' ' A' ' 2' ' ' THR . 8.8 ttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -154.78 64.49 0.66 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.48 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -84.48 123.68 30.53 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.6 HD12 HG12 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 14' ' ' CYS . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.679 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.817 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' O ' ' HB1' ' A' ' 56' ' ' ALA . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.61 HG22 ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.702 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.89 60.02 1.72 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.43 124.51 31.41 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.853 -178.501 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.79 0.328 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -59.4 126.34 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 111.415 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.536 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 -94.14 135.3 35.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.762 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.502 ' HE2' ' HB3' ' A' ' 62' ' ' TYR . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.697 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 57' ' ' VAL . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 28' ' ' VAL . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 25' ' ' VAL . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.697 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.667 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.536 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 9.0 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.797 HG21 HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 49' ' ' SER . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' HG22 ' A' ' 48' ' ' THR . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.828 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.807 HG23 ' HA ' ' A' ' 65' ' ' THR . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.807 ' HA ' HG23 ' A' ' 54' ' ' THR . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.82 98.52 1.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -72.36 92.6 1.44 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.049 0.452 . . . . 0.0 110.643 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.183 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 11.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 71.6 86.63 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.454 0.645 . . . . 0.0 112.327 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 35.6 m170 -118.21 134.88 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.843 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 57' ' ' VAL . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 33' ' ' VAL . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 18' ' ' VAL . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HA ' HG12 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 27' ' ' GLY . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.546 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.893 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG21 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.885 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 49' ' ' SER . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 50' ' ' PRO . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.617 HG21 ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.843 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -131.17 69.1 1.48 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -62.19 128.09 34.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.671 -172.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.345 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 tpt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.787 HG23 ' HB3' ' A' ' 50' ' ' PRO . 23.4 m 51.83 90.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.89 117.27 34.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.854 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.741 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.578 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 53' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG13 ' HB3' ' A' ' 15' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.691 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.691 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.787 ' HB3' HG23 ' A' ' 2' ' ' THR . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 22' ' ' LEU . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 18' ' ' VAL . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.741 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.07 70.41 0.73 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.799 -174.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.235 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.751 0.31 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.669 ' HB ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -70.24 116.56 10.73 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 110.577 177.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 61.6 m80 -101.81 137.83 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 39' ' ' THR . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.626 ' HE3' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.69 HG13 ' HE2' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.737 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.921 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.62 HG13 HG21 ' A' ' 57' ' ' VAL . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 HG12 ' A' ' 18' ' ' VAL . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.626 HG21 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD12 ' HB ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG13 ' HD2' ' A' ' 46' ' ' PRO . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.674 ' HD2' HG13 ' A' ' 45' ' ' VAL . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' VAL . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 53' ' ' LEU . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 66' ' ' LEU . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.62 HG21 HG13 ' A' ' 18' ' ' VAL . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.921 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 54' ' ' THR . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -153.09 -174.29 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.37 144.53 15.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.404 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.563 -177.275 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.727 HG22 HD21 ' A' ' 42' ' ' LEU . 0.2 OUTLIER 49.51 81.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.893 172.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -128.12 141.68 51.42 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.986 -0.446 . . . . 0.0 110.09 174.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG21 ' HE2' ' A' ' 9' ' ' MET . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.566 ' HE3' HG22 ' A' ' 18' ' ' VAL . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.566 HG22 ' HE3' ' A' ' 9' ' ' MET . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.727 HD21 HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HD11 ' A' ' 53' ' ' LEU . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 50' ' ' PRO . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.875 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.875 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.62 54.13 1.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.671 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 25.8 t70 -55.44 -49.09 73.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.786 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.697 176.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.822 0.344 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -68.95 133.8 48.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -105.78 131.64 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.313 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.594 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.847 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.556 ' HD1' ' HH ' ' A' ' 62' ' ' TYR . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG21 HG12 ' A' ' 57' ' ' VAL . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HG3' ' HB1' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 44' ' ' ILE . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HB1' ' HG3' ' A' ' 23' ' ' GLU . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.787 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.847 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.418 HD13 ' HB1' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.555 HG21 HG21 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HA ' HD12 ' A' ' 53' ' ' LEU . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 50' ' ' PRO . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 64' ' ' ALA . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.869 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HH ' ' HD1' ' A' ' 17' ' ' HIS . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.2 65.81 0.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 36.7 t70 -55.3 135.45 49.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.026 -173.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--O 1.25 1.103 0 O-C-N 124.472 1.108 . . . . 0.0 111.823 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' HB3' ' H ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.3 OUTLIER -97.78 142.15 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.681 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 42.4 m170 -103.26 135.12 45.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 33' ' ' VAL . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 57' ' ' VAL . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.661 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 6' ' ' ILE . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.661 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.848 HG21 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.744 ' HB ' ' HB1' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.618 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.19 72.41 1.47 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.773 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 19.1 t0 -75.22 64.13 1.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.305 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.08 178.697 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.897 0.38 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.96 130.11 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 111.756 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.56 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 -94.68 136.19 35.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HE3' ' A' ' 9' ' ' MET . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 18' ' ' VAL . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.5 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.634 HG22 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.6 HD13 HD23 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HA ' HG13 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.62 ' HA3' HG23 ' A' ' 48' ' ' THR . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB1' ' HG3' ' A' ' 23' ' ' GLU . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.6 HD23 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.62 HG23 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HA ' HD12 ' A' ' 53' ' ' LEU . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 50' ' ' PRO . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -143.87 93.45 2.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -79.52 54.81 1.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.312 -179.752 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.17 75.13 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 15.8 m170 -104.44 117.98 35.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.797 HD23 HD13 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.765 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.882 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.765 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.903 ' HA ' HG12 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.729 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.729 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 19' ' ' LYS . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 19' ' ' LYS . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.882 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.797 HD13 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HA ' HD13 ' A' ' 53' ' ' LEU . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' ALA . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 50' ' ' PRO . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' HB1' ' A' ' 64' ' ' ALA . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 5' ' ' LYS . . . -139.52 80.17 1.76 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -70.04 -23.53 63.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.026 175.022 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.959 0.409 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.54 137.51 55.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.17 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -109.45 139.66 44.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 65' ' ' THR . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.663 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.914 HG21 ' HE1' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.914 ' HE1' HG21 ' A' ' 6' ' ' ILE . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.541 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 HG21 ' A' ' 57' ' ' VAL . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 33' ' ' VAL . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD21 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HB1' HD23 ' A' ' 42' ' ' LEU . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.541 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 HG21 ' HA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 53' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD12 HD11 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 52' ' ' ALA . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.747 ' HB ' ' HB3' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.663 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.79 83.18 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.77 153.02 26.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.614 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.69 179.233 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.777 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 53' ' ' LEU . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.729 ' HA ' HG11 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 27' ' ' GLY . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.658 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.851 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.777 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.851 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 28' ' ' VAL . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.439 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.652 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.503 HG11 HD12 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 27' ' ' GLY . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.589 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.69 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.574 HG23 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 53' ' ' LEU . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.467 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 HG11 ' A' ' 18' ' ' VAL . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.771 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 6' ' ' ILE . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.868 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.868 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 28' ' ' VAL . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' HD12 ' A' ' 53' ' ' LEU . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 50' ' ' PRO . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.908 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.908 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.625 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.437 HG23 ' HE3' ' A' ' 9' ' ' MET . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.587 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.63 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.63 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.588 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.489 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.739 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.566 HG23 ' HE3' ' A' ' 9' ' ' MET . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 HD13 ' A' ' 42' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 42' ' ' LEU . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.841 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.597 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG21 ' HB1' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' LEU . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.891 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG23 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.475 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.43 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 57' ' ' VAL . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 18' ' ' VAL . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 6' ' ' ILE . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 31' ' ' ALA . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 57' ' ' VAL . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.769 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.769 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.702 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.553 HD13 HD11 ' A' ' 42' ' ' LEU . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.73 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.41 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.448 HD12 HG11 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.695 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.828 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 HG11 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.845 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.828 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.845 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 42' ' ' LEU . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.767 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.542 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 42' ' ' LEU . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 27' ' ' GLY . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 33.7 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.588 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 5' ' ' LYS . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 35.6 m170 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.7 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.567 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 42' ' ' LEU . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.748 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD13 HD21 ' A' ' 42' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.603 HD21 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 53' ' ' LEU . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 74.5 m-70 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HE3' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.729 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' CA ' ' HB2' ' A' ' 35' ' ' TYR . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mp0 -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 53' ' ' LEU . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.766 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.485 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.994 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.994 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.655 0.264 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 18' ' ' VAL . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.851 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 6' ' ' ILE . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLY . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 31' ' ' ALA . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 28' ' ' VAL . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.851 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.787 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m170 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD23 HD22 ' A' ' 53' ' ' LEU . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.655 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HA ' HD12 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.733 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.809 HD13 HD21 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HA ' HG11 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.984 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' VAL . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 62' ' ' TYR . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' VAL . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.8 m170 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.783 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.9 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.783 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.781 ' HA ' HG11 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG11 ' HB1' ' A' ' 15' ' ' ALA . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.842 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.842 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.556 HG12 ' HE2' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.811 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 22' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.93 0.395 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.39 77.96 8.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.843 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.786 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 6.9 m80 -124.96 143.22 51.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.358 172.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.777 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 53' ' ' LEU . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.729 ' HA ' HG11 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 27' ' ' GLY . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.658 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.851 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.777 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.851 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 28' ' ' VAL . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.2 120.26 2.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.786 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 24.2 t70 -79.2 91.31 4.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.997 0.427 . . . . 0.0 112.001 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.465 173.753 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.06 114.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.266 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.71 118.5 27.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.652 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.503 HG11 HD12 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 27' ' ' GLY . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.589 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.69 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.574 HG23 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 53' ' ' LEU . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.467 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.68 44.84 1.53 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.25 99.91 1.23 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.95 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.867 176.442 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.99 125.83 25.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.022 -174.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -92.26 124.26 36.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 HG11 ' A' ' 18' ' ' VAL . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.771 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 6' ' ' ILE . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.868 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.868 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 28' ' ' VAL . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' HD12 ' A' ' 53' ' ' LEU . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 50' ' ' PRO . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.908 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.908 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.625 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.91 85.06 1.41 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.69 -35.08 79.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.282 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.72 0.295 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.45 149.43 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.17 114.49 26.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG23 ' HE3' ' A' ' 9' ' ' MET . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.587 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.63 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.63 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.588 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.489 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.739 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.03 128.51 52.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -107.07 150.01 26.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.01 177.885 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.89 147.3 53.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.844 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.9 150.95 32.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.903 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.566 HG23 ' HE3' ' A' ' 9' ' ' MET . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 HD13 ' A' ' 42' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 42' ' ' LEU . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.841 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.88 107.21 9.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -61.66 -27.67 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.447 -178.422 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.65 123.52 28.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.339 0.59 . . . . 0.0 111.074 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -118.13 135.23 54.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.597 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG21 ' HB1' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' LEU . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.891 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.73 97.7 5.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.26 130.33 42.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.237 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 O-C-N 123.713 0.633 . . . . 0.0 110.882 -177.276 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.166 0.508 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 131.34 47.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.365 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -112.96 122.71 48.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG23 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.475 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.43 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 57' ' ' VAL . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -154.25 121.78 5.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 3' ' ' HIS . 23.3 t70 -79.44 -32.1 42.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.571 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.92 -178.25 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 152.33 38.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.976 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.873 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 28.2 m170 -90.4 124.52 35.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 18' ' ' VAL . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 6' ' ' ILE . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 31' ' ' ALA . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 57' ' ' VAL . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.769 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.769 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.63 105.67 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.873 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -68.16 -53.99 21.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.457 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.683 178.812 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 m 67.43 81.5 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.243 0.544 . . . . 0.0 110.553 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.526 ' H ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.45 132.57 34.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 -178.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.702 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.553 HD13 HD11 ' A' ' 42' ' ' LEU . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.73 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.41 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.24 106.61 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' A' ' 3' ' ' HIS . 16.4 t70 -160.62 -64.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.407 0.623 . . . . 0.0 110.175 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.553 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HB3' ' H ' ' A' ' 2' ' ' THR . 8.8 ttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -154.78 64.49 0.66 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.48 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -84.48 123.68 30.53 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.448 HD12 HG11 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.695 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.828 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG11 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.845 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.828 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.845 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 42' ' ' LEU . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.767 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.89 60.02 1.72 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.43 124.51 31.41 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.853 -178.501 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.79 0.328 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -59.4 126.34 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 111.415 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.542 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 -94.14 135.3 35.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 42' ' ' LEU . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 27' ' ' GLY . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 33.7 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.588 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 5' ' ' LYS . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.82 98.52 1.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -72.36 92.6 1.44 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.049 0.452 . . . . 0.0 110.643 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.183 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 11.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 71.6 86.63 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.454 0.645 . . . . 0.0 112.327 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 m-70 -118.21 134.88 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.7 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.567 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 42' ' ' LEU . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -131.17 69.1 1.48 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -62.19 128.09 34.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.671 -172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.345 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 tpt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m 51.83 90.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 172.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.89 117.27 34.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.854 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.748 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD13 HD21 ' A' ' 42' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.603 HD21 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 53' ' ' LEU . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.07 70.41 0.73 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.799 -174.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.235 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.751 0.31 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -70.24 116.56 10.73 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 110.577 177.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 61.6 m80 -101.81 137.83 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HE3' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.729 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' CA ' ' HB2' ' A' ' 35' ' ' TYR . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mp0 -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 53' ' ' LEU . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -153.09 -174.29 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.37 144.53 15.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.404 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.563 -177.275 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER 49.51 81.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.893 172.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.708 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -128.12 141.68 51.42 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.986 -0.446 . . . . 0.0 110.09 174.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.766 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.485 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.994 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.994 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.62 54.13 1.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 25.8 t70 -55.44 -49.09 73.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.786 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.697 176.851 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.822 0.344 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -68.95 133.8 48.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -105.78 131.64 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.313 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 18' ' ' VAL . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.851 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 6' ' ' ILE . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLY . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 31' ' ' ALA . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 28' ' ' VAL . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.851 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.787 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.2 65.81 0.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.3 135.45 49.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.026 -173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 O-C-N 124.472 1.108 . . . . 0.0 111.823 -179.502 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.78 142.15 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.681 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.802 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 42.4 m170 -103.26 135.12 45.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD23 HD22 ' A' ' 53' ' ' LEU . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.655 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HA ' HD12 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.733 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.19 72.41 1.47 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.802 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 19.1 t0 -75.22 64.13 1.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.305 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.08 178.697 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.897 0.38 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.96 130.11 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 111.756 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 -94.68 136.19 35.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.809 HD13 HD21 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HA ' HG11 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.984 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.547 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' VAL . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 62' ' ' TYR . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' VAL . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -143.87 93.45 2.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -79.52 54.81 1.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.312 -179.752 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.17 75.13 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 15.8 m170 -104.44 117.98 35.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.783 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.9 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.783 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.781 ' HA ' HG11 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG11 ' HB1' ' A' ' 15' ' ' ALA . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.842 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.842 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.52 80.17 1.76 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.636 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -70.04 -23.53 63.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.026 175.022 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.959 0.409 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.54 137.51 55.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.17 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -109.45 139.66 44.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.556 HG12 ' HE2' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.811 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 22' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.79 83.18 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.77 153.02 26.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.614 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.69 179.233 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m80 . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.777 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 53' ' ' LEU . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.729 ' HA ' HG11 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 27' ' ' GLY . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.658 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.851 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.777 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.851 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 28' ' ' VAL . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.439 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.652 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.503 HG11 HD12 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 27' ' ' GLY . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.589 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.69 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.574 HG23 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 53' ' ' LEU . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.467 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 HG11 ' A' ' 18' ' ' VAL . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.771 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 6' ' ' ILE . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.868 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.868 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 29' ' ' GLN . 2.1 mm-40 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 28' ' ' VAL . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' HD12 ' A' ' 53' ' ' LEU . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 50' ' ' PRO . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.908 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.908 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.625 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.437 HG23 ' HE3' ' A' ' 9' ' ' MET . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.587 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.63 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.63 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.588 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.489 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.739 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.566 HG23 ' HE3' ' A' ' 9' ' ' MET . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 HD13 ' A' ' 42' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 42' ' ' LEU . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.841 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.597 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG21 ' HB1' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' LEU . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.891 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG23 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.475 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.43 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 57' ' ' VAL . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.2 m170 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 18' ' ' VAL . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 6' ' ' ILE . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 31' ' ' ALA . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 57' ' ' VAL . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.769 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.769 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.702 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.553 HD13 HD11 ' A' ' 42' ' ' LEU . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.73 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.41 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.448 HD12 HG11 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.695 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.828 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 HG11 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.845 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.828 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.845 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 42' ' ' LEU . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.767 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.542 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 42' ' ' LEU . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 27' ' ' GLY . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 9.0 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.588 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 5' ' ' LYS . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 35.6 m170 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.7 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.567 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 42' ' ' LEU . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.748 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD13 HD21 ' A' ' 42' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.603 HD21 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 53' ' ' LEU . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 61.6 m80 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HE3' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.729 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' CA ' ' HB2' ' A' ' 35' ' ' TYR . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 53' ' ' LEU . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.766 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.485 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.994 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.994 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.655 0.264 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 18' ' ' VAL . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.851 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 6' ' ' ILE . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLY . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 31' ' ' ALA . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 28' ' ' VAL . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.851 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.787 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m170 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD23 HD22 ' A' ' 53' ' ' LEU . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.655 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HA ' HD12 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.733 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.809 HD13 HD21 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HA ' HG11 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.984 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' VAL . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 62' ' ' TYR . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' VAL . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.8 m170 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.783 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.9 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.783 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.781 ' HA ' HG11 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG11 ' HB1' ' A' ' 15' ' ' ALA . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.842 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.842 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.556 HG12 ' HE2' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.811 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 22' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.93 0.395 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.39 77.96 8.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.843 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.786 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 6.9 m80 -124.96 143.22 51.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.358 172.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -126.3 149.89 48.84 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.427 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -111.28 135.59 51.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.8 131.92 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.96 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -142.23 164.69 29.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.123 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.73 -49.14 4.14 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.092 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 36.3 mtm -85.45 -164.76 1.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.748 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -110.92 -73.16 0.69 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.58 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 8.9 p -179.79 -174.83 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.767 0.318 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.777 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 28.5 t70 54.52 -96.95 0.06 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -29.03 69.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.188 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 12.7 m -68.62 -41.37 79.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.077 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.52 -23.85 62.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.937 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.76 -45.46 86.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.014 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -71.86 -33.09 68.13 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.276 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.09 -48.73 87.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.848 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -63.4 -38.69 92.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.448 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -43.23 93.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.046 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.29 -33.61 76.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.126 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.559 HD23 HD22 ' A' ' 53' ' ' LEU . 10.0 mt -66.44 -45.31 80.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.177 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.729 ' HA ' HG11 ' A' ' 28' ' ' VAL . 32.3 mt-10 -75.82 -13.24 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -21.68 59.43 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 27' ' ' GLY . 77.3 t -86.13 120.32 72.35 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.69 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.49 5.89 1.79 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 123.01 2.474 . . . . 0.0 113.259 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.658 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -96.38 -6.2 58.8 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.847 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.2 p -78.25 144.62 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.277 0.56 . . . . 0.0 111.017 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -111.06 -50.55 2.93 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.619 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.55 98.64 2.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.256 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -98.76 105.74 17.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.901 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -116.48 109.91 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 176.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 7.5 t -94.19 134.79 30.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.851 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -99.02 95.77 7.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 0.0 110.09 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.777 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -59.71 -43.69 95.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.435 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 11.6 Cg_exo -72.05 -7.39 20.95 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.966 1.777 . . . . 0.0 112.239 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.851 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.6 OUTLIER -102.96 -32.41 9.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.645 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.22 62.74 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.3 159.91 37.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.537 -0.331 . . . . 0.0 110.26 -176.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -123.17 133.69 54.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.521 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -108.11 77.29 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 ' H ' ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -97.52 122.76 40.96 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.575 0.702 . . . . 0.0 111.254 -175.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.42 132.88 36.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.434 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 28' ' ' VAL . 2.4 pt -132.4 162.1 40.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.155 0.502 . . . . 0.0 111.065 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -74.24 150.05 87.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.492 176.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 45' ' ' VAL . 21.2 Cg_exo -67.36 62.92 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.96 2.44 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.2 -34.64 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 172.3 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.655 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -132.95 134.75 24.84 Favored Pre-proline 0 N--CA 1.437 -1.104 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.048 179.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.748 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.8 Cg_exo -66.52 -27.85 46.0 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.344 2.029 . . . . 0.0 112.741 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 49' ' ' SER . 3.6 p-10 -73.12 -22.72 60.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -37.24 50.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.79 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.9 mt -72.41 -41.25 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.664 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.2 m -57.92 -48.53 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.463 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.6 78.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.92 83.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.95 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 80.9 t -68.01 -41.91 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.695 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.9 71.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.103 0.477 . . . . 0.0 111.248 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.23 82.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.096 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.75 10.52 39.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.128 0.489 . . . . 0.0 110.694 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.75 -6.78 67.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.87 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -105.05 -165.73 1.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 7.9 tmtm? -135.72 132.11 36.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.88 153.48 35.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.979 0.419 . . . . 0.0 110.391 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -135.56 -166.57 1.87 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -151.94 124.26 8.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.329 0.585 . . . . 0.0 110.144 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.2 120.26 2.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.889 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.786 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 24.2 t70 -79.2 91.31 4.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.997 0.427 . . . . 0.0 112.001 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.465 173.753 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.06 114.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.266 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.71 118.5 27.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.311 0.577 . . . . 0.0 110.67 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.8 mp -95.59 162.11 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.348 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -104.91 130.18 53.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.059 0.457 . . . . 0.0 110.289 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 HG11 ' A' ' 18' ' ' VAL . 41.0 mm -110.97 108.0 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.563 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 ' OG1' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -132.84 177.12 7.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.06 -174.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.09 -41.93 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.123 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 8.2 mtm -86.66 -106.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -82.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.865 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -155.12 -137.66 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -175.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 11' ' ' CYS . 4.9 p-10 -42.32 -54.68 3.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -29.71 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.309 0.576 . . . . 0.0 110.9 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.652 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 20.6 m -80.23 -43.88 20.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -62.92 -23.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.91 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.6 83.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.956 0.408 . . . . 0.0 110.822 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -62.19 -41.37 98.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.503 HG11 HD12 ' A' ' 6' ' ' ILE . 53.3 t -65.65 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.59 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.771 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.12 -39.85 93.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.69 84.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.74 -51.19 58.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.414 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -75.44 -6.73 51.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.567 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -18.94 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 109.761 170.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 27' ' ' GLY . 69.2 t -85.59 124.97 70.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.818 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.34 -17.39 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.232 2.621 . . . . 0.0 113.26 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.589 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -77.97 -15.36 81.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.187 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.17 126.52 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -87.26 -47.8 8.54 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.256 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.26 132.52 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.25 120.13 32.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.85 0.357 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -118.12 108.86 15.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.0 t -95.22 133.38 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.183 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -98.03 106.05 18.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.82 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.69 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -58.34 -44.19 98.93 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.604 179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 92.2 Cg_endo -82.37 -4.85 11.79 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 121.482 1.455 . . . . 0.0 112.449 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.5 OUTLIER -105.61 -28.7 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.266 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 20.6 73.83 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.543 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -128.77 151.03 50.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 -175.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.01 112.85 24.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' HB3' ' A' ' 3' ' ' HIS . 1.2 mt-30 -96.17 102.65 14.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -118.81 136.33 54.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.146 0.498 . . . . 0.0 111.382 -172.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.18 108.8 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.435 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.574 HG23 HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -105.39 166.18 3.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.95 125.18 78.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.76 110.54 0.44 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.005 2.47 . . . . 0.0 112.27 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -33.65 2.44 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.595 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -70.36 131.4 44.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.777 0.323 . . . . 0.0 110.411 176.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -74.47 117.13 59.6 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.641 -174.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.2 Cg_exo -73.58 -24.79 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.72 2.28 . . . . 0.0 112.04 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.74 -20.39 61.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.28 55.53 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 50' ' ' PRO . 6.4 mt -68.09 -42.3 80.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.25 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.1 m -56.64 -49.27 75.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.446 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.73 71.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.236 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.97 83.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.781 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 53' ' ' LEU . 45.8 t -67.99 -44.68 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.793 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.97 -39.86 91.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.909 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.45 -13.45 77.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.39 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -84.13 10.18 10.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.4 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.29 -17.88 58.36 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.511 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.9 OUTLIER -88.33 -179.63 6.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 101.8 8.67 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -103.61 147.07 27.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.23 0.538 . . . . 0.0 111.264 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.467 ' OG1' ' HE2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.86 -156.36 0.67 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -153.76 137.18 15.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.695 178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.68 44.84 1.53 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -69.25 99.91 1.23 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.95 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.867 176.442 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.99 125.83 25.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.022 -174.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -92.26 124.26 36.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -103.08 153.08 20.65 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.522 -176.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 0.8 OUTLIER -114.86 126.26 54.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.251 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 HD12 HG11 ' A' ' 18' ' ' VAL . 23.3 mm -86.07 126.77 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.896 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.21 148.61 52.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 110.668 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.35 -60.92 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.771 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 11.7 mtp -87.69 146.67 25.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.85 -63.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.696 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 11.5 p -178.66 161.45 1.29 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t0 61.49 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.223 0.952 . . . . 0.0 112.792 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m 70.87 -45.79 0.62 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.9 -174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 2.2 m -61.92 -45.55 93.23 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.459 170.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.9 70.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.479 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.02 64.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -48.37 81.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.916 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 6' ' ' ILE . 64.5 t -63.13 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.364 177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 22' ' ' LEU . 19.7 tttp -57.51 -45.81 84.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.8 -39.74 94.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.18 94.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.393 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 42' ' ' LEU . 16.8 mt -67.36 -44.66 78.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.259 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.868 ' HA ' HG11 ' A' ' 28' ' ' VAL . 83.6 mt-10 -75.5 -9.68 58.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.191 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -73.49 -24.08 60.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 78.9 t -80.64 124.42 81.95 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.654 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 12.3 Cg_exo -70.73 4.41 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.221 2.614 . . . . 0.0 113.594 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -99.07 3.34 58.38 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.148 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.868 HG11 ' HA ' ' A' ' 23' ' ' GLU . 1.3 p -87.13 148.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.1 0.476 . . . . 0.0 111.119 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 29' ' ' GLN . 2.1 mm-40 -123.63 -41.79 2.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.557 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 102.33 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.99 0.424 . . . . 0.0 110.581 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -103.29 100.16 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 110.17 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.073 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.94 123.4 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.7 102.73 15.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.993 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.696 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -60.28 -43.67 94.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.446 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 8.4 Cg_exo -71.83 -18.16 28.49 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.539 1.493 . . . . 0.0 112.925 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.3 OUTLIER -105.31 -22.64 13.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.89 0.376 . . . . 0.0 111.166 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.82 29.14 61.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.646 -177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -108.68 147.31 32.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.727 0.299 . . . . 0.0 110.779 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -125.16 113.96 18.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.844 0.354 . . . . 0.0 110.183 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.26 88.57 3.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.966 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -94.93 111.59 23.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.342 0.592 . . . . 0.0 111.066 -177.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.06 99.51 9.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 28' ' ' VAL . 9.3 pt -103.28 162.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.594 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.44 129.81 64.59 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.134 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -49.66 107.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.158 2.572 . . . . 0.0 112.294 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.3 -38.25 1.33 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -74.72 132.63 41.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.196 173.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 125.15 78.68 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.527 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' HD12 ' A' ' 53' ' ' LEU . 43.6 Cg_endo -69.61 -18.47 37.71 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.306 2.004 . . . . 0.0 112.345 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -24.76 62.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.49 61.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.203 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 50' ' ' PRO . 7.7 mt -67.88 -43.63 78.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.9 m -56.87 -51.02 70.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.68 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.8 71.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.15 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.08 -47.87 75.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.651 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.908 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.91 -34.99 79.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.932 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.72 -19.29 77.92 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.62 16.79 3.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.158 0.504 . . . . 0.0 110.792 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.15 -14.7 61.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.629 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 2.7 m-85 -91.37 -174.85 4.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.67 120.11 34.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.908 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.52 127.88 52.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.14 0.495 . . . . 0.0 110.991 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.625 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -127.91 -174.67 3.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -153.39 148.53 26.82 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 118.463 0.574 . . . . 0.0 110.83 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.91 85.06 1.41 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.781 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.69 -35.08 79.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.282 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.72 0.295 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.45 149.43 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.17 114.49 26.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.974 0.416 . . . . 0.0 109.88 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -83.48 152.8 24.77 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -107.77 135.2 49.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.392 0.615 . . . . 0.0 111.323 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG23 ' HE3' ' A' ' 9' ' ' MET . 31.6 mm -86.27 119.75 34.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.66 151.3 49.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.714 0.292 . . . . 0.0 110.73 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.32 -38.79 2.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.18 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.587 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 16.6 mtm -83.28 166.54 18.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 110.987 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -73.23 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.97 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.5 p 177.78 173.2 0.58 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.111 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.63 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 57.2 -94.96 0.05 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.12 173.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -33.1 57.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.584 . . . . 0.0 110.562 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 9' ' ' MET . 6.4 m -66.14 -46.03 78.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.611 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.89 65.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.33 -46.28 64.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.471 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -71.1 -32.83 69.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.469 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -65.3 -46.8 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -59.23 -41.8 89.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -62.6 -44.8 95.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.37 80.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 110.136 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.15 -47.89 69.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.191 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -72.62 -14.65 61.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.316 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -21.52 60.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.27 119.11 71.37 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.502 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.27 -19.93 66.25 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.938 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.49 -19.55 77.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.032 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 44' ' ' ILE . 97.3 t -90.45 111.37 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -80.53 -37.12 32.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.55 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.01 134.18 14.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -115.99 94.5 4.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.051 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 1.3 mp -83.94 71.53 10.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.191 0.52 . . . . 0.0 110.007 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.0 p -73.73 144.07 13.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.463 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -125.1 93.3 3.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.069 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.63 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 16.7 p90 -58.79 -41.68 90.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.588 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 6.2 Cg_exo -72.64 -12.33 26.71 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 121.586 1.524 . . . . 0.0 112.181 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -104.99 -29.13 10.65 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.978 0.418 . . . . 0.0 110.738 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.08 25.45 48.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.703 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.8 162.93 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.369 0.128 . . . . 0.0 110.839 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -139.11 115.19 10.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.605 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -87.52 106.07 17.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -95.35 129.64 42.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 111.513 -175.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.67 99.6 8.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -117.06 164.58 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -173.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.4 124.74 90.77 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.856 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 115.3 2.1 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.608 2.205 . . . . 0.0 111.415 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.6 -26.58 4.56 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.65 129.23 36.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -75.15 118.28 69.39 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -177.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 9.7 Cg_exo -70.97 -22.03 27.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.668 2.246 . . . . 0.0 111.975 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.45 -21.5 63.72 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.02 -31.04 61.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.927 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.06 -43.84 61.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.328 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -49.26 78.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.267 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.37 75.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.259 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.29 89.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.922 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.6 t -71.81 -41.74 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 110.721 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.71 67.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.11 -1.47 72.57 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.897 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.71 4.46 47.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.136 0.493 . . . . 0.0 110.587 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.07 75.09 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.489 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 24.3 m-85 -115.41 -168.03 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -134.46 124.39 25.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.382 177.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.739 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -113.46 130.77 56.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.105 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.25 -169.85 1.82 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -154.07 138.01 16.31 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.467 -177.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.03 128.51 52.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.16 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -107.07 150.01 26.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.659 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.01 177.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.89 147.3 53.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.844 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.9 150.95 32.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.903 175.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -143.63 157.38 44.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 39' ' ' THR . 0.3 OUTLIER -114.86 142.32 46.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 -178.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.566 HG23 ' HE3' ' A' ' 9' ' ' MET . 14.8 mm -108.29 131.78 57.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.445 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.05 38.99 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.669 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.67 -42.67 2.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.966 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -85.67 169.63 13.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 111.642 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.9 -73.42 0.42 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 31.7 p -174.1 160.91 3.51 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 17.1 t0 53.27 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 167.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -55.11 -31.63 61.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.35 0.595 . . . . 0.0 110.622 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 40.0 m -65.72 -45.11 83.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.527 175.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.22 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.569 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.5 75.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.362 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -63.22 -43.06 99.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.288 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.4 t -63.02 -48.3 88.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.538 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -59.59 -44.25 93.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.512 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 tt0 -65.59 -40.8 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.65 -36.61 82.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.217 0.532 . . . . 0.0 109.854 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 HD13 ' A' ' 42' ' ' LEU . 21.9 mt -68.35 -51.14 47.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.601 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -75.41 -11.21 60.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.296 -174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.64 -20.98 59.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 27' ' ' GLY . 66.3 t -85.63 125.59 68.8 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.426 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.54 4.86 1.14 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.976 2.451 . . . . 0.0 113.548 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -95.24 -14.47 48.17 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.788 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.32 123.23 47.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.833 0.349 . . . . 0.0 110.271 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -49.24 8.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.084 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.44 117.1 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.355 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . . . -105.14 99.37 8.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.06 80.03 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.181 0.515 . . . . 0.0 110.207 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 t -76.73 121.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -87.51 98.34 11.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 109.913 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -60.55 -42.59 89.15 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 56.3 Cg_endo -69.15 -19.31 39.2 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.411 1.407 . . . . 0.0 112.825 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -99.4 -17.52 17.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.776 0.322 . . . . 0.0 111.043 -175.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.28 33.19 72.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.446 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -136.15 160.84 37.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.53 0.205 . . . . 0.0 110.613 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -127.17 127.3 44.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.698 0.285 . . . . 0.0 110.846 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.22 91.63 3.73 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.15 137.75 53.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.357 0.599 . . . . 0.0 111.47 -172.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.38 125.09 43.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.593 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -111.27 155.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.809 0.337 . . . . 0.0 110.913 -178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -75.13 127.43 86.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.52 117.38 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.266 2.644 . . . . 0.0 112.618 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.88 -37.59 2.13 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.31 130.69 40.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.191 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.92 132.46 29.58 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.506 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 36.0 Cg_endo -66.73 -11.92 33.85 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.556 2.171 . . . . 0.0 113.025 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -27.77 65.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.66 -35.8 65.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.056 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.607 HD13 HD11 ' A' ' 42' ' ' LEU . 5.6 mt -68.18 -44.44 75.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.433 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -58.05 -48.64 79.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.66 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.06 74.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.955 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.78 78.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.802 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.841 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 54.7 t -66.89 -43.8 89.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.663 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.5 -34.96 79.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.062 0.458 . . . . 0.0 111.049 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.02 -16.93 78.02 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.5 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.86 12.05 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.191 0.519 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.43 -6.75 71.51 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.032 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 8.8 m-85 -98.81 -169.45 1.78 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.7 0.286 . . . . 0.0 110.255 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.17 117.07 17.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -104.82 149.22 25.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.7 -167.59 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.7 133.98 13.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.494 . . . . 0.0 111.402 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.88 107.21 9.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.995 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -61.66 -27.67 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.486 -0.768 . . . . 0.0 110.447 -178.422 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.65 123.52 28.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.339 0.59 . . . . 0.0 111.074 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -118.13 135.23 54.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -108.78 137.43 46.73 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 126.84 45.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.348 0.594 . . . . 0.0 111.033 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.05 122.32 38.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.22 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -122.27 144.97 48.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.888 0.375 . . . . 0.0 110.108 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.35 -50.25 3.81 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.597 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 18.5 mtm -87.15 157.32 19.4 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.01 26.37 1.53 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 25.9 p -154.27 159.22 41.16 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.615 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -51.9 -38.43 56.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.009 175.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.61 64.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.095 0.474 . . . . 0.0 110.898 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m -95.71 -39.58 9.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.39 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -60.69 -29.45 69.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.438 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.08 -41.28 98.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -38.46 86.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.81 -44.49 96.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.023 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -60.36 -40.1 89.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.507 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.49 -42.78 95.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.1 89.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.839 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.73 -47.16 70.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.432 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.6 -13.28 62.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.598 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -73.12 -26.68 61.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.522 0.677 . . . . 0.0 109.244 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' GLY . 75.2 t -85.55 121.23 73.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.275 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.52 -7.3 20.61 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.797 2.332 . . . . 0.0 112.97 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.35 -11.12 84.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.959 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 44' ' ' ILE . 64.4 t -92.16 117.83 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -39.93 33.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.13 132.26 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.054 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.21 105.17 8.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.007 0.432 . . . . 0.0 110.693 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 107.44 15.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG21 ' HB1' ' A' ' 15' ' ' ALA . 2.2 p -87.9 149.43 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.1 0.476 . . . . 0.0 110.85 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.07 103.57 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -54.55 -52.44 69.74 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.004 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 57.5 Cg_endo -69.33 -13.14 35.25 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.853 1.702 . . . . 0.0 113.087 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -105.62 -16.64 14.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.789 0.328 . . . . 0.0 110.862 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 25.68 70.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.852 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.88 160.68 35.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.834 0.349 . . . . 0.0 110.764 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -115.53 125.19 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.421 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 99.94 12.53 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -122.14 130.76 53.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -174.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.69 113.23 26.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.969 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 28' ' ' VAL . 1.1 pt -114.11 170.09 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.037 0.446 . . . . 0.0 111.154 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.9 136.96 38.14 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.437 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.96 68.55 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.109 2.539 . . . . 0.0 112.393 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.94 -34.32 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -75.76 128.87 36.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.03 110.71 11.78 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' A' ' 53' ' ' LEU . 54.1 Cg_endo -72.81 -20.39 22.66 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.974 1.783 . . . . 0.0 112.517 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.83 -23.32 59.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.78 54.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.895 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 50' ' ' PRO . 12.9 mt -66.81 -41.78 86.96 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.3 m -57.25 -49.79 74.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.506 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.66 76.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.998 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.55 93.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.908 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' LEU . 66.4 t -70.27 -41.57 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.672 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.79 67.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.961 0.41 . . . . 0.0 111.065 175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.58 4.28 76.02 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.198 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.38 8.67 43.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.74 -6.53 62.66 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.96 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -106.5 -173.67 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.891 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -123.0 126.41 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 175.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.02 146.23 46.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.134 0.492 . . . . 0.0 111.296 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 -165.08 1.51 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 135.74 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.197 0.523 . . . . 0.0 110.479 -178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.73 97.7 5.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.963 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.26 130.33 42.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.237 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 O-C-N 123.713 0.633 . . . . 0.0 110.882 -177.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.166 0.508 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.57 131.34 47.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.365 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -112.96 122.71 48.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -95.7 152.3 18.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.834 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG23 ' A' ' 39' ' ' THR . 3.2 tptm -108.33 128.18 54.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.811 0.339 . . . . 0.0 110.191 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -98.8 118.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.72 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.56 155.95 46.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.04 0.448 . . . . 0.0 111.09 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.09 -45.23 2.11 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.432 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.475 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -86.79 -176.42 5.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.01 40.14 1.31 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.73 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.43 ' SG ' ' HD1' ' A' ' 35' ' ' TYR . 3.9 p 47.93 -130.1 1.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.907 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -25.31 133.44 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.713 0.805 . . . . 0.0 113.036 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.5 m 82.71 -56.16 0.19 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.336 1.054 . . . . 0.0 110.245 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.475 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 61.0 m -65.35 -41.18 94.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 0.0 109.878 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.09 67.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.189 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.75 75.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.466 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -43.54 96.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.073 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.501 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -48.6 76.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.945 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -38.45 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.08 -35.87 82.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.163 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.0 -45.53 81.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.295 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -74.27 -12.53 60.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -17.19 59.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.186 0.517 . . . . 0.0 110.055 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.49 123.04 73.33 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.777 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.19 92.88 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.998 1.799 . . . . 0.0 111.452 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.5 -19.21 0.1 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -87.72 113.35 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.236 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -44.4 51.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.108 0.48 . . . . 0.0 109.949 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -154.96 125.7 7.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.386 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.73 116.42 31.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -116.74 91.26 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.069 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 16.5 t -87.22 125.16 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 m -98.15 104.47 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.635 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' HB2' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.96 -44.58 95.14 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.546 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 22.9 Cg_exo -65.1 -22.26 61.97 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.799 1.666 . . . . 0.0 112.694 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.484 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -104.96 -10.08 17.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.155 -176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.09 22.42 66.91 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.37 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -123.47 151.55 42.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.937 0.399 . . . . 0.0 110.725 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -114.54 116.83 29.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.141 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.08 89.84 4.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.988 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -101.44 134.98 43.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.386 0.613 . . . . 0.0 110.944 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.48 103.14 15.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.15 163.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.022 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.8 t -86.14 127.62 60.99 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.794 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.14 116.56 3.13 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.646 2.23 . . . . 0.0 111.666 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.95 -39.74 1.6 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.45 137.19 42.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.634 0.254 . . . . 0.0 110.443 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.31 119.85 78.48 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.637 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.26 -21.45 41.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.591 2.194 . . . . 0.0 112.316 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.29 -14.03 60.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.79 59.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.669 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 57' ' ' VAL . 6.7 mt -72.19 -45.02 62.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.385 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -49.7 74.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.651 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.78 -31.67 72.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.197 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.65 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.677 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 43.3 t -67.45 -42.0 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.48 -32.84 74.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 0.0 111.329 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.21 6.01 84.11 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.366 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.67 14.88 27.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.178 0.514 . . . . 0.0 110.722 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.88 -11.27 68.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.701 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -100.45 -178.34 3.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 109.54 14.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -101.96 149.89 23.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.949 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.76 -155.24 0.58 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.566 173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -153.6 140.22 18.89 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.872 0.305 . . . . 0.0 110.263 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -154.25 121.78 5.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.665 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 3' ' ' HIS . 23.3 t70 -79.44 -32.1 42.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.571 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.92 -178.25 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.953 0.406 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 152.33 38.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.976 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.873 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 28.2 m170 -90.4 124.52 35.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.488 0.661 . . . . 0.0 109.636 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -98.75 149.63 22.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.491 177.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -107.13 129.2 54.87 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.811 -175.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 18' ' ' VAL . 14.3 mm -94.34 126.54 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -113.19 141.98 46.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.145 0.498 . . . . 0.0 111.295 -173.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.87 -63.09 4.53 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 0.4 OUTLIER -88.6 108.1 19.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 37.88 4.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.848 0.356 . . . . 0.0 111.786 -172.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HA ' ' HD1' ' A' ' 35' ' ' TYR . 26.0 p -150.56 156.1 40.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.138 0.494 . . . . 0.0 111.878 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.667 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.8 t70 -50.61 -44.66 57.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.464 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -55.49 -32.47 62.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.751 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 92.3 m -92.3 -37.18 12.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.514 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -64.63 -27.31 68.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.754 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.83 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 6' ' ' ILE . 61.1 t -63.07 -44.95 99.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.967 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 31' ' ' ALA . 3.0 tttm -61.86 -43.56 98.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.664 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.49 -42.78 99.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.597 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.35 87.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.56 -43.87 79.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.376 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -68.89 -23.33 64.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -20.21 60.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.261 0.553 . . . . 0.0 109.611 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.4 t -84.98 117.29 68.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 176.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 37.1 Cg_exo -61.49 -21.4 71.85 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.091 2.527 . . . . 0.0 113.199 -175.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.67 -12.02 73.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 44' ' ' ILE . 93.0 t -94.98 116.54 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 110.427 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -40.0 28.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.078 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.5 136.39 15.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.287 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . -126.88 104.31 7.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mp -109.08 97.45 7.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.487 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.5 t -92.54 129.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.95 111.64 23.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.258 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 2.3 t80 -54.93 -52.58 69.66 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.79 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 18.5 Cg_endo -59.21 -32.87 97.81 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.395 2.064 . . . . 0.0 113.27 -177.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -23.71 17.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.98 26.06 73.36 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 p -124.69 152.11 44.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.92 0.39 . . . . 0.0 111.102 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -109.5 114.85 28.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.445 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.51 93.06 9.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -98.3 139.06 34.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.458 0.646 . . . . 0.0 111.495 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.03 86.65 2.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.64 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 28' ' ' VAL . 7.0 pt -92.86 165.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.144 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.04 122.26 72.66 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.938 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.62 113.07 0.74 Allowed 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.102 2.534 . . . . 0.0 112.123 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.18 -39.35 1.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.49 115.47 15.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 170.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -73.93 124.85 90.49 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 -173.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.1 Cg_exo -64.41 -21.01 66.71 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.556 2.17 . . . . 0.0 112.06 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.93 -24.99 63.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.99 -33.71 57.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.678 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 57' ' ' VAL . 20.6 mt -69.54 -42.65 74.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.525 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.2 m -58.0 -50.3 73.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.461 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.9 72.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.22 -48.57 72.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.734 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.769 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 59.7 t -68.15 -43.04 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.816 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.64 -28.5 69.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.114 0.483 . . . . 0.0 110.967 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.63 0.24 82.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.242 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 13.16 31.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 -13.68 60.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.402 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.47 -161.12 0.81 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.1 mmtm -134.0 141.66 47.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.769 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.62 149.56 45.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.541 . . . . 0.0 111.658 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -137.9 -157.34 0.77 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 171.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.54 124.62 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.63 105.67 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.873 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -68.16 -53.99 21.15 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.457 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.683 178.812 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 m 67.43 81.5 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.243 0.544 . . . . 0.0 110.553 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.526 ' H ' ' HB2' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.45 132.57 34.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 110.0 -178.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -92.39 156.4 17.24 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.294 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 130.67 55.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.25 122.1 48.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.68 162.56 31.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.161 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.08 -59.91 4.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.7 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.702 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 20.6 mtp -81.86 140.3 34.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.53 34.52 0.43 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p 46.85 172.99 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.911 1.284 . . . . 0.0 113.93 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 7.7 t0 58.21 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.255 -175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m 71.6 -48.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.705 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.0 m -57.57 -41.28 80.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.508 0.67 . . . . 0.0 110.114 172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.04 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.466 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.97 74.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 -40.8 91.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.497 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.57 -45.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.112 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -57.87 -50.94 71.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.942 178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.0 -34.48 78.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.295 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -38.34 84.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 109.74 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.553 HD13 HD11 ' A' ' 42' ' ' LEU . 36.7 mt -67.11 -50.99 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.142 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -75.38 -5.15 43.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.496 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -25.63 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.6 t -79.55 124.41 83.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.201 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.25 -14.71 39.96 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 123.119 2.546 . . . . 0.0 113.163 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.16 -8.68 81.42 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.421 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.77 118.01 41.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.012 0.435 . . . . 0.0 110.243 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -86.29 -33.6 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.882 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.73 147.87 17.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.293 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . . . -133.68 92.96 3.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.201 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -88.88 77.99 7.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.73 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.0 t -69.83 118.69 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.318 0.58 . . . . 0.0 110.93 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.76 83.73 7.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.881 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -54.24 -43.05 96.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 12.7 Cg_exo -70.13 -12.74 32.74 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.701 1.601 . . . . 0.0 112.603 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.51 -20.49 13.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 110.869 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.9 26.28 60.7 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.666 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -127.98 176.28 7.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 110.443 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -137.21 117.75 13.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.113 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.5 mp0 -87.09 94.54 9.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -86.69 159.93 19.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.371 0.605 . . . . 0.0 111.589 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' OE1' ' A' ' 29' ' ' GLN . . . -134.9 102.4 5.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.414 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -92.74 150.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.231 -170.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.53 126.26 67.09 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.017 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.7 121.5 6.62 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.951 2.434 . . . . 0.0 112.37 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.97 -35.1 3.5 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.41 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -76.17 135.37 39.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 0.0 111.292 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -86.24 123.58 71.34 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.422 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 16.7 Cg_exo -68.08 -21.66 42.48 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.699 2.266 . . . . 0.0 112.924 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.06 -19.41 61.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.601 0.715 . . . . 0.0 109.098 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -29.3 60.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.854 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.52 -43.16 60.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.646 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -49.7 75.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.63 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.27 77.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.028 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.5 83.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.823 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 56.7 t -69.78 -40.71 79.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.31 -30.16 70.98 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.961 0.41 . . . . 0.0 111.351 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -12.43 80.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.396 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 18.1 6.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.204 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.1 -5.1 84.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.241 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 1.5 m-85 -104.76 -176.79 3.18 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.59 119.02 28.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 0.0 110.213 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -111.87 126.48 55.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.048 0.451 . . . . 0.0 111.158 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.618 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.48 -167.28 1.22 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.68 138.95 17.5 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.417 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.24 106.61 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.513 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' A' ' 3' ' ' HIS . 16.4 t70 -160.62 -64.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.407 0.623 . . . . 0.0 110.175 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.553 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HB3' ' H ' ' A' ' 2' ' ' THR . 8.8 ttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -154.78 64.49 0.66 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.48 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -84.48 123.68 30.53 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.651 HD13 HD11 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -111.74 149.21 31.98 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.972 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -105.92 124.73 50.04 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.448 HD12 HG11 ' A' ' 18' ' ' VAL . 31.6 mm -94.02 130.6 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.038 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.82 162.6 36.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.231 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.53 -52.55 1.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.695 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.0 mtt -86.17 163.62 17.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -77.65 0.16 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.81 0.338 . . . . 0.0 111.181 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.828 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 18.7 p 173.87 141.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.721 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.89 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.773 0.67 . . . . 0.0 111.543 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 m 70.32 -44.99 0.58 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.317 0.647 . . . . 0.0 110.244 -174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 3.8 m -59.63 -44.75 93.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.549 0.69 . . . . 0.0 109.361 172.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.89 67.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.426 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.27 74.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -66.64 -36.51 82.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.367 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG11 HD12 ' A' ' 6' ' ' ILE . 57.5 t -63.52 -45.87 96.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.622 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -60.54 -39.54 88.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.673 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.49 -46.69 88.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.946 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.16 -47.3 71.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.276 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -75.19 -12.61 60.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.235 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -73.76 -26.67 60.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.1 t -85.59 118.5 70.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.455 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 27.7 Cg_exo -63.09 -8.44 14.14 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.095 2.53 . . . . 0.0 112.757 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.845 ' HA3' HG21 ' A' ' 48' ' ' THR . . . -80.77 -11.19 84.22 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.675 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.0 128.28 46.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 -38.64 9.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.77 110.79 3.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.963 0.411 . . . . 0.0 110.351 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.69 91.35 5.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 75.97 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.462 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 5.9 t -78.94 128.4 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.109 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -106.14 109.02 20.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.82 -177.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.828 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -65.04 -44.82 72.45 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.324 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.0 -6.23 17.79 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.855 1.704 . . . . 0.0 112.379 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 3.8 mttp -105.51 -30.11 9.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.5 20.01 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.597 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.68 24.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.67 0.272 . . . . 0.0 110.853 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -130.55 134.06 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.843 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -106.87 99.58 9.14 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -103.93 110.6 22.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.283 -175.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.05 110.74 15.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.83 161.48 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.7 124.0 89.88 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.17 107.11 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.283 2.655 . . . . 0.0 112.726 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.15 -32.87 2.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.202 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.845 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -67.67 133.33 49.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -75.84 112.37 19.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 15.6 Cg_exo -68.62 -13.53 37.43 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.828 2.352 . . . . 0.0 112.663 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -24.99 65.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.74 -34.41 75.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.455 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 42' ' ' LEU . 5.7 mt -74.21 -44.57 52.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.862 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.5 77.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.03 74.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.929 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.68 69.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.622 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 60.5 t -67.13 -42.65 88.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.13 73.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.141 0.496 . . . . 0.0 111.001 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.03 -5.91 89.33 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.37 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -90.24 9.59 27.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 110.483 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.33 57.06 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.518 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -95.77 -159.34 0.72 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 127.06 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.923 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.767 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.69 133.49 55.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.914 0.388 . . . . 0.0 110.499 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.584 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -124.76 -158.61 0.83 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -152.79 133.9 14.18 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -133.89 60.02 1.72 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.703 -174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.43 124.51 31.41 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.853 -178.501 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.79 0.328 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 m -59.4 126.34 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.408 . . . . 0.0 111.415 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.542 ' CD2' ' HG3' ' A' ' 41' ' ' GLN . 66.1 m80 -94.14 135.3 35.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.338 0.589 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.57 HD13 HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -114.07 161.73 17.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.294 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.598 ' HB2' HG23 ' A' ' 65' ' ' THR . 2.9 mtpt -116.56 139.66 50.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 mm -113.61 127.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.322 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.03 166.23 24.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.1 -52.87 2.2 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 14' ' ' CYS . 26.0 mtm -86.36 170.27 12.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -75.38 0.24 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.167 0.508 . . . . 0.0 111.219 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -172.01 -178.48 2.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.263 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 4.6 t0 20.94 122.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 168.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.2 m 85.21 -49.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.381 1.072 . . . . 0.0 109.907 -172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 46.8 m -64.57 -42.02 95.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.604 0.716 . . . . 0.0 109.279 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.44 62.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.685 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -71.33 -42.34 68.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.957 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.79 -44.51 86.34 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.995 175.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.29 -42.13 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.162 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -57.85 -45.78 85.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.72 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 3.2 mt-10 -62.89 -42.54 99.81 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.459 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.43 86.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.201 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 42' ' ' LEU . 16.9 mt -67.85 -46.16 72.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.37 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -73.81 -10.79 60.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.295 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -15.93 58.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.238 0.542 . . . . 0.0 109.903 173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 27' ' ' GLY . 70.5 t -85.08 121.39 74.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.64 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.8 Cg_exo -64.22 -16.98 58.01 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.974 2.449 . . . . 0.0 113.133 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -86.83 -1.8 84.79 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.744 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.06 125.54 46.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -85.04 -47.28 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.829 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -154.4 149.06 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.56 101.26 4.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.812 0.339 . . . . 0.0 110.774 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.09 89.9 3.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.448 . . . . 0.0 110.078 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -81.8 124.07 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.746 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.69 107.38 19.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.29 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.85 -54.17 57.06 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.1 Cg_endo -76.84 0.54 9.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.763 1.642 . . . . 0.0 112.668 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 20.4 tttt -105.77 -19.79 13.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 110.137 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.25 29.34 73.2 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.85 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -135.32 156.59 48.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -177.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -118.45 115.45 24.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.977 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HG3' ' CD2' ' A' ' 3' ' ' HIS . 9.0 tt0 -97.75 93.72 6.54 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -118.43 160.85 20.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.249 0.547 . . . . 0.0 111.37 -174.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.07 122.9 40.32 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.303 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -113.63 152.84 15.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.828 0.347 . . . . 0.0 110.91 -177.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.79 133.45 79.38 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.766 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.73 107.71 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.085 2.523 . . . . 0.0 112.267 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.0 -28.48 2.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -75.0 163.52 27.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.252 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 1.6 m -131.88 128.78 21.69 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.928 0.394 . . . . 0.0 110.958 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 53' ' ' LEU . 15.8 Cg_exo -67.72 -24.9 40.47 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.974 2.449 . . . . 0.0 113.559 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.88 -20.62 60.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 -39.72 46.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.01 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 50' ' ' PRO . 3.7 mt -67.02 -40.59 87.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -55.62 -51.19 68.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.296 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.0 -32.77 74.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.085 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.28 83.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.004 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.588 ' HB ' ' CB ' ' A' ' 64' ' ' ALA . 37.8 t -73.92 -39.01 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.665 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -64.32 -34.64 78.61 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.066 0.46 . . . . 0.0 110.621 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.49 -14.54 79.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.346 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -86.89 11.24 13.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 0.0 111.034 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.88 -4.04 78.16 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.605 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 13.5 m-85 -104.84 -174.16 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 111.75 17.38 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.579 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.588 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . . . -120.68 159.77 24.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 111.172 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 5' ' ' LYS . 12.7 t -156.05 -159.27 0.88 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.51 141.04 21.64 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.299 0.571 . . . . 0.0 110.825 -176.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.82 98.52 1.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.521 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -72.36 92.6 1.44 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.049 0.452 . . . . 0.0 110.643 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.183 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 11.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 71.6 86.63 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.454 0.645 . . . . 0.0 112.327 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 35.6 m170 -118.21 134.88 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.56 148.15 33.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.261 -176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -110.19 133.58 53.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.173 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.5 mp -85.41 127.59 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.166 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.64 148.48 52.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.85 -37.07 3.21 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.498 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.7 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.0 mtt -81.99 163.72 21.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.77 0.319 . . . . 0.0 110.842 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.07 19.65 11.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.541 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p 49.7 150.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.512 1.125 . . . . 0.0 113.533 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 26.1 t0 64.99 136.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.59 -171.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m 67.57 -55.81 0.47 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.145 0.578 . . . . 0.0 110.366 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 81.0 m -58.67 -45.68 88.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.576 0.703 . . . . 0.0 109.561 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.47 -24.01 62.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.465 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.863 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.55 -49.92 75.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.032 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.25 -44.69 96.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.834 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -60.21 -45.5 92.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.78 -41.43 95.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.45 84.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.168 0.508 . . . . 0.0 110.057 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.765 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.619 ' HA ' HG11 ' A' ' 28' ' ' VAL . 28.4 mt-10 -70.43 -18.6 63.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.083 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -76.97 -12.38 59.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.806 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.1 t -85.55 124.66 71.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.965 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 25.0 Cg_exo -64.28 -20.47 66.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.788 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 -5.56 90.01 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.417 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -85.66 137.67 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.103 0.478 . . . . 0.0 110.396 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -99.46 -44.51 6.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 131.49 9.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.692 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.48 90.87 3.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.57 63.84 4.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.431 0.634 . . . . 0.0 110.265 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.9 t -68.87 113.04 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.443 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 m -104.97 104.19 13.9 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.767 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.567 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 5.1 p90 -62.61 -41.5 73.3 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.067 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 61.3 Cg_endo -71.59 -12.85 29.64 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 121.251 1.301 . . . . 0.0 111.98 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -31.69 12.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.72 13.59 72.26 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 150.63 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.205 0.526 . . . . 0.0 111.309 -175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.28 115.11 29.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.201 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 78.34 2.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -104.42 132.38 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.605 0.717 . . . . 0.0 111.144 -176.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.01 26.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.538 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -104.72 172.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.084 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -81.53 144.65 53.35 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.057 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 45' ' ' VAL . 13.0 Cg_endo -56.98 102.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.56 2.174 . . . . 0.0 111.664 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.7 -32.27 1.84 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 123.31 24.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.854 0.359 . . . . 0.0 110.047 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 127.27 87.42 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 28.6 Cg_endo -65.15 -24.29 59.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.154 1.903 . . . . 0.0 112.129 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -24.27 63.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.41 60.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.859 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 HD21 ' A' ' 42' ' ' LEU . 4.1 mt -71.68 -45.55 61.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.403 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -49.76 73.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.55 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.19 -32.5 73.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.194 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.27 85.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.782 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 44.6 t -70.18 -43.89 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.654 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.15 -29.62 70.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.869 0.366 . . . . 0.0 111.334 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.86 -2.56 84.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.423 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.93 16.04 22.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 110.742 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -2.3 83.26 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.852 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 25.4 m-85 -108.49 -170.81 1.74 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.82 129.49 40.53 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.72 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -117.48 141.02 48.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -163.38 0.95 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.92 132.8 13.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.377 0.608 . . . . 0.0 111.466 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -131.17 69.1 1.48 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.265 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -62.19 128.09 34.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.671 -172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.13 -0.938 . . . . 0.0 109.345 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 tpt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m 51.83 90.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 172.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.89 117.27 34.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.854 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 58.7 mt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.799 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -94.26 125.31 38.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 mm -84.85 130.28 36.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -120.52 151.19 39.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.279 0.562 . . . . 0.0 111.277 -174.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.73 -71.43 2.72 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.748 ' HG3' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.43 79.7 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.15 11.73 15.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 p -159.42 147.52 17.53 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.994 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 35' ' ' TYR . 22.7 t0 21.78 138.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 163.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 m 70.18 -52.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.604 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 5.4 m -63.77 -44.66 92.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 173.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.03 70.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.425 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.17 60.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.484 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -44.8 95.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.821 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG13 HG22 ' A' ' 57' ' ' VAL . 45.2 t -62.73 -47.4 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.98 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -54.85 -51.12 66.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.918 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -38.32 88.47 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.023 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.54 95.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.09 0.471 . . . . 0.0 109.934 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD13 HD21 ' A' ' 42' ' ' LEU . 70.8 mt -68.55 -46.19 70.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.593 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.87 -12.49 61.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.948 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -73.83 -19.76 60.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 109.666 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 27' ' ' GLY . 76.9 t -85.62 124.41 71.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.815 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.43 -17.09 38.83 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.313 2.675 . . . . 0.0 113.367 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -75.36 -16.45 80.61 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.5 t -95.85 127.31 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.58 -44.0 9.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.058 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.55 125.1 7.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.22 89.24 3.35 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mt -86.16 76.38 9.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.315 0.579 . . . . 0.0 110.644 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 4.1 t -84.58 124.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.179 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -105.32 114.84 29.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.448 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -58.31 -52.09 77.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.957 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 35' ' ' TYR . 35.5 Cg_endo -64.28 -14.27 42.92 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.982 . . . . 0.0 113.042 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.3 OUTLIER -105.3 -14.72 15.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.2 23.13 63.81 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.338 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -132.45 151.17 51.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.042 0.448 . . . . 0.0 111.764 -175.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -112.87 119.32 37.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.528 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.51 98.33 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.603 HD21 HD13 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -96.43 114.96 26.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.212 0.529 . . . . 0.0 112.121 -171.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.69 8.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.62 157.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.135 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 59.4 t -85.05 132.53 45.35 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.527 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 45' ' ' VAL . 1.6 Cg_endo -43.06 132.16 6.09 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.689 2.926 . . . . 0.0 112.358 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.04 -41.4 2.14 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 119.53 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.733 0.301 . . . . 0.0 110.589 175.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 132.74 77.26 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.377 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 53' ' ' LEU . 37.7 Cg_exo -61.2 -23.94 78.1 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.413 2.076 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -22.69 63.43 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.708 0.766 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.83 -34.05 69.0 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.012 -177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.3 mt -72.49 -43.24 63.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.529 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -49.8 76.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.731 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.89 76.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.6 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.642 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 53' ' ' LEU . 60.4 t -67.09 -48.57 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.869 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.76 -20.23 66.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.82 63.48 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.783 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.78 17.5 23.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 111.04 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 -5.56 80.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.312 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.748 ' HD1' ' HG3' ' A' ' 9' ' ' MET . 29.3 m-85 -106.62 178.58 4.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 19.8 tptm -120.86 132.78 55.18 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -125.52 138.99 53.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 0.0 111.448 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -120.29 -157.35 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 171.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -151.3 132.65 14.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.509 0.671 . . . . 0.0 111.754 -174.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.07 70.41 0.73 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.899 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -26.25 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.799 -174.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.235 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.751 0.31 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -70.24 116.56 10.73 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 110.577 177.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 61.6 m80 -101.81 137.83 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.515 0.674 . . . . 0.0 110.388 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 66.2 mt -126.92 133.94 50.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.545 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HE3' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -97.43 134.82 40.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.056 0.455 . . . . 0.0 110.984 -177.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -94.56 130.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.808 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 132.39 49.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.013 0.435 . . . . 0.0 111.036 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.2 -31.05 8.71 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.924 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.729 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 5.8 mtt -86.09 -178.33 6.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.778 0.323 . . . . 0.0 111.077 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -115.61 -59.79 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 5.6 p -154.57 -154.94 0.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' CA ' ' HB2' ' A' ' 35' ' ' TYR . 35.6 t70 -46.22 -46.74 17.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.85 0.86 . . . . 0.0 113.264 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.23 -27.25 61.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.175 0.512 . . . . 0.0 111.122 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 11.5 m -87.59 -44.74 11.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.382 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.98 68.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.354 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.35 -45.57 93.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.63 -39.61 94.0 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.51 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.77 -46.88 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.003 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -62.88 -39.17 93.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.4 -45.64 90.11 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.876 0.369 . . . . 0.0 110.373 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.64 -39.54 84.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.812 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.17 -42.97 83.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.498 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -67.82 -21.88 65.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -81.68 -13.18 58.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.027 0.442 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 27' ' ' GLY . 54.8 t -86.22 124.84 69.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.44 -17.19 43.92 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.983 2.455 . . . . 0.0 113.032 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -85.99 0.29 87.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.111 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' ILE . 14.8 t -86.43 127.49 40.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.916 0.388 . . . . 0.0 110.691 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -96.81 -46.67 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.157 0.503 . . . . 0.0 109.712 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -154.08 119.28 5.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.5 112.02 20.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.8 mt -116.08 98.75 6.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.673 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.2 t -89.73 133.27 32.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -99.11 114.13 26.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.126 0.488 . . . . 0.0 111.318 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CD2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -63.34 -44.33 82.38 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.408 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 72.2 Cg_endo -76.13 -15.89 18.09 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 121.464 1.443 . . . . 0.0 112.688 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.07 -27.43 13.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.0 110.677 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 6' ' ' ILE . . . 71.59 30.9 65.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -136.77 158.91 43.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.798 0.332 . . . . 0.0 111.165 -177.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -114.14 126.61 55.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.515 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -112.06 98.51 7.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -115.24 154.83 28.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.28 -174.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.36 111.0 17.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.991 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -118.94 165.21 14.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.929 0.395 . . . . 0.0 111.276 -174.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.88 131.0 84.4 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.338 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 43.93 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.251 2.634 . . . . 0.0 113.36 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.08 -33.36 0.64 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 132.42 40.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.987 -0.606 . . . . 0.0 110.247 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.61 121.94 81.81 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 -12.59 35.87 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.255 1.97 . . . . 0.0 112.136 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.31 -26.21 61.86 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.54 58.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.128 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.6 mt -70.3 -41.87 72.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -56.91 -50.83 71.36 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.559 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.86 74.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.951 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.94 92.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.003 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 53' ' ' LEU . 58.4 t -70.51 -39.94 76.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.873 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.17 70.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.073 0.463 . . . . 0.0 110.592 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.64 10.71 68.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.272 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.75 5.35 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 110.629 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.02 -7.89 53.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.938 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -106.0 -156.06 0.56 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.11 132.84 27.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -119.52 148.53 43.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.891 0.377 . . . . 0.0 110.697 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -175.14 3.37 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.83 133.44 14.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.539 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -153.09 -174.29 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.348 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.37 144.53 15.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.404 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.563 -177.275 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER 49.51 81.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.893 172.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.708 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -128.12 141.68 51.42 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.986 -0.446 . . . . 0.0 110.09 174.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.766 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -123.67 152.6 41.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.517 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -113.56 130.92 56.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.9 mm -97.4 134.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.647 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.84 143.61 34.87 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.668 0.271 . . . . 0.0 110.984 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.7 -45.44 1.39 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.738 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 4.7 mtm -80.64 146.12 31.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.598 0.237 . . . . 0.0 110.507 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -62.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.442 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 9.3 p -176.48 177.77 1.4 Allowed 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.588 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' SER . 14.7 t0 23.16 124.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 166.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 29.4 m 84.0 -43.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.393 1.077 . . . . 0.0 109.713 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 74.3 m -63.53 -42.04 98.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.16 -25.82 58.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.238 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.11 51.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.236 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -38.42 90.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.616 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.35 -43.66 91.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.081 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -59.87 -41.28 91.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.838 0.351 . . . . 0.0 110.414 176.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 1.1 tp10 -63.47 -44.73 93.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.55 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.91 -35.07 79.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -67.52 -48.86 65.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.2 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.55 -11.53 60.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.324 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 20' ' ' GLU . 3.4 mptt -73.87 -18.46 60.92 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -85.4 120.18 72.95 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.7 -21.86 73.09 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.074 2.516 . . . . 0.0 113.251 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 -18.93 77.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.376 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -87.52 124.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.06 0.457 . . . . 0.0 110.467 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.93 -34.33 13.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.085 0.469 . . . . 0.0 110.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.03 152.6 30.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.577 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' LEU . . . -144.84 81.23 1.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.055 0.455 . . . . 0.0 110.423 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.29 69.6 9.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.328 0.585 . . . . 0.0 110.521 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 3.8 t -72.69 118.02 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.686 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 4.4 m -98.6 112.28 24.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -59.94 -44.28 96.48 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.163 178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.72 -8.79 22.99 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.671 1.581 . . . . 0.0 112.377 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 0.7 OUTLIER -104.96 -35.05 7.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.593 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.64 19.46 68.27 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -131.57 159.5 38.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.282 . . . . 0.0 110.877 -174.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -118.87 118.67 32.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.861 0.362 . . . . 0.0 110.946 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.75 72.16 3.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -92.34 161.81 14.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.905 -177.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.14 17.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.485 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -113.83 168.74 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 -177.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.29 129.74 56.84 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -45.07 106.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.841 2.361 . . . . 0.0 112.092 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.82 -37.64 1.76 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.05 118.96 19.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.139 0.495 . . . . 0.0 109.872 173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -85.31 124.1 72.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.397 -174.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 23.4 Cg_exo -66.4 -9.4 23.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.135 2.557 . . . . 0.0 112.775 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.6 -27.45 63.13 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.27 60.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.018 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 57' ' ' VAL . 14.2 mt -70.0 -43.06 72.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.654 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -56.95 -47.87 79.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.08 -33.0 74.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.216 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.7 88.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.228 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.994 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 40.7 t -72.2 -40.84 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.976 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.96 67.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.8 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.72 11.53 71.46 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.754 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.29 10.42 40.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.431 0.634 . . . . 0.0 109.674 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.38 74.85 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.808 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.81 -165.45 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.394 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 124.31 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.649 0.261 . . . . 0.0 110.418 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.994 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -108.17 147.53 31.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 110.92 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -161.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.75 123.96 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.462 0.649 . . . . 0.0 110.798 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -123.62 54.13 1.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.995 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 25.8 t70 -55.44 -49.09 73.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.786 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.697 176.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.822 0.344 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 m -68.95 133.8 48.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -105.78 131.64 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.313 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 161.64 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.82 132.94 56.14 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.984 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 18' ' ' VAL . 1.2 mp -95.29 126.34 47.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.056 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 150.64 52.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.941 0.4 . . . . 0.0 110.951 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -45.3 2.87 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.362 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 33.9 mtm -84.66 170.88 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.202 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -82.99 0.16 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.851 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 7.8 p 174.07 135.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.854 -171.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.561 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 38.2 t0 69.1 139.24 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.673 0.608 . . . . 0.0 110.613 -175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m 68.86 -57.0 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 110.382 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 12.6 m -58.83 -46.83 86.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 109.377 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.89 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.871 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.39 24.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.521 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.88 -39.94 91.14 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 6' ' ' ILE . 48.1 t -64.73 -46.59 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.248 176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -49.93 72.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.17 -36.58 83.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.307 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.19 90.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 109.957 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 18' ' ' VAL . 84.6 mt -67.14 -49.24 65.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.211 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 6.2 mt-10 -71.5 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.685 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -16.8 60.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 109.65 173.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLY . 56.2 t -84.91 123.74 73.44 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.401 175.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 38.3 Cg_exo -61.63 -16.11 46.14 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 123.112 2.541 . . . . 0.0 113.51 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -77.83 -13.51 83.35 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 31' ' ' ALA . 62.5 t -95.48 121.72 46.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.649 0.261 . . . . 0.0 110.442 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -34.18 12.98 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.043 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.4 114.69 4.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 28' ' ' VAL . . . -113.16 113.51 25.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.5 90.46 3.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 110.015 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 15.6 t -76.36 117.35 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.38 105.06 14.93 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.892 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.851 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -61.49 -42.28 83.53 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.771 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HD3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 Cg_exo -74.96 -5.28 16.61 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.623 1.549 . . . . 0.0 112.212 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 6.2 mttm -106.57 -39.07 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.144 0.497 . . . . 0.0 110.226 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.96 18.93 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.246 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -127.0 150.85 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.782 0.325 . . . . 0.0 111.637 -176.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -108.26 107.49 18.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.317 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 94.51 9.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.926 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -98.67 124.33 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.973 -172.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.01 79.96 4.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -95.82 160.36 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.365 -174.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 53.7 t -85.13 129.49 55.74 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.524 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 38.6 Cg_exo -63.35 72.98 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.517 2.811 . . . . 0.0 112.625 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.91 -39.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.77 129.61 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.469 172.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.5 119.2 75.38 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.691 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.18 -14.25 40.63 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.789 2.326 . . . . 0.0 112.73 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.99 -26.59 67.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.75 65.46 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.028 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.4 mt -71.53 -45.95 60.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.719 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -58.84 -49.37 78.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.602 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.59 78.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.16 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.649 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.787 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 58.3 t -68.97 -42.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.639 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -65.44 -28.93 69.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.998 0.427 . . . . 0.0 111.51 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.58 -14.71 72.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.352 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.9 14.58 8.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.121 0.486 . . . . 0.0 111.427 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.1 -4.2 70.78 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 4.6 m-85 -107.0 -169.7 1.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -129.61 129.82 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -115.09 145.64 42.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.055 0.455 . . . . 0.0 110.752 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.76 -152.61 0.48 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.8 135.07 15.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.111 0.482 . . . . 0.0 111.15 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.2 65.81 0.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.3 135.45 49.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.026 -173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 O-C-N 124.472 1.108 . . . . 0.0 111.823 -179.502 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.78 142.15 29.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.681 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.802 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 42.4 m170 -103.26 135.12 45.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.525 0.679 . . . . 0.0 110.822 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.42 158.8 24.61 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.066 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -116.91 126.5 53.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.833 0.349 . . . . 0.0 110.659 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.29 129.5 37.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.62 157.54 43.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.836 0.35 . . . . 0.0 110.382 -177.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.64 -63.76 4.36 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.67 171.99 10.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 169.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -31.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.95 165.32 37.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -170.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 23.49 131.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 166.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m 70.99 -51.65 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.697 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -61.83 -39.13 90.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.53 62.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.544 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.6 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.287 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -58.11 -49.38 77.15 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.002 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.51 -43.24 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.535 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -49.36 77.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.679 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -37.46 86.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.05 89.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 110.123 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD23 HD22 ' A' ' 53' ' ' LEU . 17.5 mt -67.86 -47.49 68.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.595 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.58 -13.53 62.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.437 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -74.2 -19.47 60.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.088 0.471 . . . . 0.0 109.79 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 27' ' ' GLY . 71.4 t -85.15 125.61 69.76 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.009 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.91 -14.17 40.55 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.018 2.479 . . . . 0.0 112.96 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.618 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -82.57 -13.37 78.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.204 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.07 123.66 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -95.47 -33.07 12.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.716 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.21 125.0 7.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.976 0.417 . . . . 0.0 110.304 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.85 96.06 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.015 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -111.34 99.25 8.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.199 0.523 . . . . 0.0 109.988 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 13.1 t -81.72 121.41 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.276 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.65 100.29 11.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.819 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.71 93.89 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.961 -176.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.43 -19.31 61.24 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.608 1.539 . . . . 0.0 112.927 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -27.63 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.22 16.84 70.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.812 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.36 158.69 23.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 0.0 110.573 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -117.56 128.54 55.05 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.787 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.655 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 1.4 mm-40 -97.06 99.98 11.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.41 135.42 54.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.385 0.612 . . . . 0.0 111.582 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.12 109.34 13.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.475 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -104.04 158.97 5.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.553 -178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -71.45 125.36 91.81 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.603 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.11 111.15 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.181 2.587 . . . . 0.0 112.228 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.77 -37.84 1.89 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.47 114.74 15.51 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 123.35 88.91 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HA ' HD12 ' A' ' 53' ' ' LEU . 33.5 Cg_endo -65.58 -12.84 36.9 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 113.194 -177.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HA ' ' OG1' ' A' ' 54' ' ' THR . 14.1 t70 -71.42 -22.16 61.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.435 0.635 . . . . 0.0 109.351 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.96 -30.19 58.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 50' ' ' PRO . 14.8 mt -74.78 -38.05 62.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.557 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER -60.52 -49.42 77.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.088 175.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.7 -33.28 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.768 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.88 -48.85 78.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.834 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 66.1 t -66.77 -41.68 88.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.896 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -62.79 -37.29 86.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.11 -10.7 85.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.276 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 11.07 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.064 0.459 . . . . 0.0 110.892 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.63 -5.52 73.63 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.907 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 10.8 m-85 -105.89 -164.69 1.04 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -134.78 134.78 41.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.733 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -123.96 137.59 54.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.093 0.473 . . . . 0.0 111.274 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -130.19 -157.61 0.83 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -151.95 133.13 14.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.532 0.682 . . . . 0.0 111.112 177.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.19 72.41 1.47 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.533 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.802 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 19.1 t0 -75.22 64.13 1.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.305 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.08 178.697 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.897 0.38 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.96 130.11 40.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 111.756 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m170 -94.68 136.19 35.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -109.88 147.53 33.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.828 -179.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tptm -100.47 126.65 46.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.93 127.97 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.6 151.49 38.17 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.786 0.327 . . . . 0.0 111.05 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.67 -24.92 5.44 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.475 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.3 mtm -81.81 -14.83 55.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.559 0.219 . . . . 0.0 111.421 -176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 10' ' ' THR . 19.8 m 62.35 15.31 7.57 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.328 0.585 . . . . 0.0 111.114 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER 47.64 -168.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.083 -178.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 35' ' ' TYR . 34.3 t70 54.69 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.757 0.823 . . . . 0.0 112.645 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 74.9 m 70.42 -48.4 0.64 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.231 -173.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 59.6 m -61.91 -39.67 92.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 169.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -74.95 -24.39 58.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.282 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 -47.05 28.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.708 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -34.52 77.35 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.584 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 9' ' ' MET . 1.3 t -66.31 -41.02 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 2.4 tttm -56.81 -48.89 76.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.394 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.5 -36.31 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.279 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.56 97.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.032 0.444 . . . . 0.0 110.121 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.809 HD13 HD21 ' A' ' 42' ' ' LEU . 18.4 mt -67.82 -43.79 78.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.559 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HA ' HG11 ' A' ' 28' ' ' VAL . 10.9 mt-10 -75.21 -9.74 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.602 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -74.49 -23.72 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 173.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 27' ' ' GLY . 74.9 t -77.25 120.03 79.89 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.791 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.43 -0.15 6.23 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.992 2.461 . . . . 0.0 113.515 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -90.56 -1.32 74.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.543 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.984 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -95.2 146.4 6.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 0.0 111.524 -178.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -101.39 -42.68 6.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.115 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.13 122.56 2.16 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.87 100.21 12.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -98.34 70.61 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.275 0.56 . . . . 0.0 110.094 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.1 t -73.16 124.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.31 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.0 m -97.51 102.25 13.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.247 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.547 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -60.16 -43.27 93.41 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.297 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.07 -17.0 45.76 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.727 1.618 . . . . 0.0 112.797 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -105.77 -17.63 14.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 111.429 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.24 70.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.911 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.55 157.46 46.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -124.19 123.36 40.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.578 0.228 . . . . 0.0 111.162 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.88 101.19 13.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -97.34 115.94 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.745 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.8 83.23 4.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -99.78 153.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 t -76.28 130.55 77.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.815 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.3 118.92 3.56 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.916 2.411 . . . . 0.0 111.809 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.73 -35.18 2.83 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -75.4 127.64 33.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.884 0.373 . . . . 0.0 110.921 177.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.9 116.68 56.2 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.24 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.35 -17.17 14.91 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.433 2.089 . . . . 0.0 112.794 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -19.64 61.26 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.792 0.806 . . . . 0.0 109.023 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -30.5 60.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.828 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' VAL . 16.6 mt -70.42 -42.31 71.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.132 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -49.8 75.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.757 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.39 -34.83 79.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.832 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.53 92.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 62' ' ' TYR . 99.3 t -68.98 -42.99 82.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.592 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.87 72.52 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.295 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.32 -13.77 82.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.561 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.55 15.56 6.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 111.207 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.03 -8.4 79.8 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.335 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' VAL . 39.9 m-85 -93.48 -177.6 4.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -128.48 92.54 3.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.0 109.89 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 57' ' ' VAL . . . -97.01 149.56 21.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.27 0.557 . . . . 0.0 111.623 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.43 -157.12 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.937 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -153.14 148.88 27.46 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.79 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 3' ' ' HIS . . . -143.87 93.45 2.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.109 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -79.52 54.81 1.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.312 -179.752 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.17 75.13 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 68' ' ' ASP . 15.8 m170 -104.44 117.98 35.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 42' ' ' LEU . 2.6 mm? -104.93 164.08 12.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.662 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -122.8 130.79 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.932 0.396 . . . . 0.0 110.767 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' A' ' 9' ' ' MET . 1.3 mp -91.12 127.97 43.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -128.65 141.7 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -175.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -33.86 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.961 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.783 ' HB3' ' CB ' ' A' ' 14' ' ' CYS . 2.8 mtt -85.38 153.9 22.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -60.73 2.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.833 0.349 . . . . 0.0 111.486 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.9 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.4 p -171.44 -140.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -172.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -53.66 -34.33 58.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -23.12 59.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.32 0.581 . . . . 0.0 111.092 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.783 ' CB ' ' HB3' ' A' ' 9' ' ' MET . 1.3 m -110.16 -39.3 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.559 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -67.58 -22.33 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.007 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.41 73.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -32.2 70.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.448 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -64.21 -46.39 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.058 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.68 -39.79 92.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.171 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.13 -45.77 91.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.864 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.69 76.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.62 -42.01 83.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.325 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.781 ' HA ' HG11 ' A' ' 28' ' ' VAL . 26.7 mt-10 -71.97 -20.91 61.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.85 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.03 -16.55 61.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.853 175.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 27' ' ' GLY . 55.2 t -85.68 124.77 70.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.719 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 23.5 Cg_exo -64.58 -14.24 43.36 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.777 2.318 . . . . 0.0 112.584 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 25' ' ' VAL . . . -80.21 -2.03 88.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.763 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -95.36 145.0 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.011 0.434 . . . . 0.0 110.904 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -108.22 -47.13 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.607 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.53 12.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.779 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.53 110.95 16.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -121.8 98.39 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.431 0.634 . . . . 0.0 110.089 178.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG11 ' HB1' ' A' ' 15' ' ' ALA . 3.3 t -87.3 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.429 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -94.16 92.8 7.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.044 0.449 . . . . 0.0 110.078 178.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.9 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.18 -44.31 99.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.62 -8.08 13.59 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.549 1.5 . . . . 0.0 112.329 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 3.6 mttp -105.63 -20.22 13.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.268 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.05 24.46 76.48 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.645 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -123.52 163.16 21.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.38 131.21 43.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.06 102.59 11.56 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 4' ' ' LEU . 8.0 mt -117.23 128.29 54.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.027 0.442 . . . . 0.0 111.517 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.0 22.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.55 156.31 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.28 124.12 87.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.009 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.76 100.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.122 2.548 . . . . 0.0 111.806 177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.9 -32.33 0.98 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -74.84 126.82 31.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.804 0.335 . . . . 0.0 110.528 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.6 m -78.25 126.08 83.95 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.846 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 25.8 Cg_exo -63.38 -11.8 27.49 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.996 2.464 . . . . 0.0 113.059 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.91 -26.73 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.99 -31.89 61.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.912 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 57' ' ' VAL . 13.5 mt -70.85 -46.82 62.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.654 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -60.02 -47.47 85.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.425 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.85 74.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.394 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.17 87.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.701 0.286 . . . . 0.0 110.761 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.842 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 47.3 t -71.6 -40.36 71.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.125 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.47 -31.39 72.58 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.089 0.471 . . . . 0.0 110.534 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.18 63.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.193 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -96.81 8.59 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.606 . . . . 0.0 109.944 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 18.18 56.0 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.575 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD1' ' HG2' ' A' ' 9' ' ' MET . 30.0 m-85 -136.91 -161.3 1.15 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.63 130.74 52.23 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.311 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.842 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -114.61 144.64 43.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.868 0.366 . . . . 0.0 111.161 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -152.58 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 129.98 11.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.066 0.46 . . . . 0.0 109.967 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.52 80.17 1.76 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.626 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.636 ' HA ' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -70.04 -23.53 63.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.026 175.022 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.959 0.409 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.54 137.51 55.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.17 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -109.45 139.66 44.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 1.7 tp -99.14 143.36 29.49 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -109.98 133.23 53.4 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.198 0.523 . . . . 0.0 110.706 -174.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.556 HG12 ' HE2' ' A' ' 9' ' ' MET . 0.9 OUTLIER -103.29 134.42 44.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 -175.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 145.52 45.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.105 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.17 5.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.664 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.811 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 8.1 mtm -85.84 156.49 20.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.869 0.366 . . . . 0.0 111.138 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -67.27 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.365 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.56 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 4.5 p -165.71 -147.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.564 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 27.8 p-10 -44.37 -41.56 6.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -50.86 72.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.366 0.603 . . . . 0.0 110.739 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 9' ' ' MET . 1.7 m -70.07 -36.55 75.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.509 177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . . . -63.84 -28.2 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.686 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -62.84 -48.81 77.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.725 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -48.34 70.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.202 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.84 -43.09 98.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.536 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -59.35 -43.46 92.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 16' ' ' ALA . 16.9 mt-10 -64.48 -44.19 91.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.996 0.427 . . . . 0.0 110.207 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -60.37 -39.54 87.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.2 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 42' ' ' LEU . 86.5 mt -67.74 -46.51 71.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.554 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.39 -15.45 62.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -15.3 54.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.51 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -82.72 124.48 77.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.809 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.95 92.91 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.041 1.827 . . . . 0.0 111.141 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.97 -16.86 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -90.6 110.69 22.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.024 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -83.59 -29.8 27.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.417 . . . . 0.0 110.34 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -153.58 140.15 18.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.231 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.65 82.11 2.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.082 0.468 . . . . 0.0 110.464 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 41.2 mt -88.13 72.28 9.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 110.483 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 2.7 t -72.81 116.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.46 117.33 29.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.164 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HD1' ' HB2' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -63.99 -44.31 77.86 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.326 179.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.29 -21.03 20.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.763 1.642 . . . . 0.0 112.904 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -102.33 -12.97 17.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.898 -175.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.35 30.94 77.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.991 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -135.76 155.82 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.822 -176.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . . . -113.37 116.62 29.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.749 0.309 . . . . 0.0 110.514 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 9.4 tt0 -84.97 96.45 9.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 22' ' ' LEU . 4.2 mt -102.56 113.78 27.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.269 0.556 . . . . 0.0 111.537 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.02 80.78 8.29 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -85.05 151.89 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.73 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.16 123.98 89.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.29 115.05 1.82 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.969 2.446 . . . . 0.0 111.929 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.33 -40.78 1.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 123.77 26.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -74.3 120.06 79.52 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.647 -177.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' SER . 14.9 Cg_exo -68.01 -9.91 27.19 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -22.83 63.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.658 0.742 . . . . 0.0 109.124 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.28 65.27 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.097 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 42' ' ' LEU . 12.4 mt -75.15 -42.06 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.392 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.12 -50.46 71.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.784 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.67 -33.6 76.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.784 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 -48.85 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 64' ' ' ALA . 39.5 t -69.68 -41.55 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' TYR . . . -60.09 -30.9 69.55 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.903 0.382 . . . . 0.0 111.007 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.57 -13.48 83.15 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.408 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.37 15.3 6.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.323 0.582 . . . . 0.0 110.632 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.32 -8.56 76.47 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.281 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 16.5 m-85 -93.51 177.75 5.92 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -116.82 110.13 17.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -109.82 145.96 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.204 0.526 . . . . 0.0 111.659 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 5' ' ' LYS . 8.1 t -141.46 -155.18 0.57 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.12 141.75 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.49 0.586 . . . . 0.0 111.311 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.79 83.18 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.364 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.77 153.02 26.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.614 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.69 179.233 . . . . . . . . 0 0 . 1 stop_ save_